Arcutis Biotherapeutics: ZORYVE’s Multi-Indication Momentum as a Catalyst for Sustained Dermatology Leadership
Explore our in-depth analysis of Arcutis Biotherapeutics (ARQT), focusing on ZORYVE's potential to disrupt the topical corticosteroid market and drive multi-year revenue growth in immuno-dermatology.
                        



